Advances Toward COVID-19 Therapies Special Issue
- PMID: 35138859
- DOI: 10.1021/acs.jmedchem.2c00178
Advances Toward COVID-19 Therapies Special Issue
Similar articles
-
Targeting SARS-CoV-2 Proteases and Polymerase for COVID-19 Treatment: State of the Art and Future Opportunities.J Med Chem. 2022 Feb 24;65(4):2716-2746. doi: 10.1021/acs.jmedchem.0c01140. Epub 2020 Nov 13. J Med Chem. 2022. PMID: 33186044 Free PMC article. Review.
-
Potential SARS-CoV-2 protease Mpro inhibitors: repurposing FDA-approved drugs.Phys Biol. 2021 Feb 9;18(2):025001. doi: 10.1088/1478-3975/abcb66. Phys Biol. 2021. PMID: 33203811
-
Selection of SARS-CoV-2 main protease inhibitor using structure-based virtual screening.Future Med Chem. 2022 Jan;14(2):61-79. doi: 10.4155/fmc-2020-0380. Epub 2021 Nov 24. Future Med Chem. 2022. PMID: 34814706 Free PMC article.
-
Bioactive Terpenes and Their Derivatives as Potential SARS-CoV-2 Proteases Inhibitors from Molecular Modeling Studies.Biomolecules. 2021 Jan 7;11(1):74. doi: 10.3390/biom11010074. Biomolecules. 2021. PMID: 33430299 Free PMC article.
-
Exploring covalent inhibitors of SARS-CoV-2 main protease: from peptidomimetics to novel scaffolds.J Enzyme Inhib Med Chem. 2025 Dec;40(1):2460045. doi: 10.1080/14756366.2025.2460045. Epub 2025 Feb 6. J Enzyme Inhib Med Chem. 2025. PMID: 39912405 Free PMC article. Review.
Cited by
-
The Ethanol Extract of Evodiae Fructus and Its Ingredient, Rutaecarpine, Inhibit Infection of SARS-CoV-2 and Inflammatory Responses.Int J Mol Sci. 2023 Jan 1;24(1):762. doi: 10.3390/ijms24010762. Int J Mol Sci. 2023. PMID: 36614206 Free PMC article.
-
Drugs for COVID-19: An Update.Molecules. 2022 Dec 5;27(23):8562. doi: 10.3390/molecules27238562. Molecules. 2022. PMID: 36500655 Free PMC article. Review.
-
Indole-3-carbinol in vitro antiviral activity against SARS-Cov-2 virus and in vivo toxicity.Cell Death Discov. 2022 Dec 15;8(1):491. doi: 10.1038/s41420-022-01280-2. Cell Death Discov. 2022. PMID: 36522315 Free PMC article.
-
Beyond the vaccines: a glance at the small molecule and peptide-based anti-COVID19 arsenal.J Biomed Sci. 2022 Sep 6;29(1):65. doi: 10.1186/s12929-022-00847-6. J Biomed Sci. 2022. PMID: 36064696 Free PMC article. Review.
-
Clinical Comparison of COVID Waves 2-5. An Inpatient Retrospective Comparative Analysis From Karachi, Pakistan.Open Forum Infect Dis. 2025 Feb 7;12(3):ofaf072. doi: 10.1093/ofid/ofaf072. eCollection 2025 Mar. Open Forum Infect Dis. 2025. PMID: 40066088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources